On the SCOTUStalk podcast, Amy Howe of Howe on the Court continues her series interviewing Supreme Court advocates. In this episode, Goodwin partner William M. Jay discusses his career arguing 17 cases before the court. Listen to the podcast here.
Related Content
- AlertMarch 25, 2025
Federal Circuit Confirms Deductibility of Hatch-Waxman Litigation Expenses
- AlertMarch 3, 2025
Supreme Court Curtails Disgorgement in Trademark Infringement Case
- AlertJanuary 30, 2025
Supreme Court to Address Article III Standing Problems in Class Actions — Again
- AlertOctober 17, 2024
Supreme Court Grants Review in ERISA Class Action Challenging Plan Sponsor’s Recordkeeping Arrangement
- AlertAugust 21, 2024
Texas Court Finds FTC Noncompete Ban Unlawful with Nationwide Effect
- AlertJuly 11, 2024
U.S. Supreme Court Significantly Curtails SEC Enforcement Forum Discretion
- AlertApril 19, 2024
Supreme Court Adopts New Standard for Establishing Adverse Employment Action Element in Title VII Cases
- AlertApril 15, 2024
Supreme Court Rejects Securities Lawsuit Based On “Pure Omission” From SEC Filings
- In the PressApril 15, 2025
EcoFactor v Google Unlikely to Result in ‘Tectonic Shifts in the Law’ (World IP Review)
- In the PressApril 8, 2025
On the Line: The Legality of Sports Prediction Markets Will Soon Be Tested (New York Law Journal)
- Awards and RankingsMarch 20, 2025
Six Goodwin Lawyers Named to Law360’s 2025 Editorial Advisory Boards
- Speaking EngagementsJanuary 23, 2025
Webinar: Cunningham v. Cornell University at the Supreme Court: An Oral Argument Readout
- Press ReleaseJanuary 9, 2025
Goodwin Succeeds in Obtaining Dismissal of Attorney General Lawsuit Against the Town of Milton at the Massachusetts Supreme Judicial Court
- Awards and RankingsJanuary 2, 2025
Massachusetts Lawyers Weekly Names Kevin Martin a 2024 Go To Lawyer for Business Litigation
- Awards and RankingsDecember 11, 2024
Goodwin Earns Top Firm and Attorney Rankings in Patexia’s 2024 CAFC Intelligence Report
- Press ReleaseDecember 6, 2024
Goodwin Releases Update to its Comprehensive Guide to Biosimilars Litigation and Regulation in the U.S.